Embecta Corp. (EMBC)

NASDAQ: EMBC · IEX Real-Time Price · USD
27.36
+0.97 (3.68%)
Feb 1, 2023, 4:00 PM EST - Market closed
3.68%
Market Cap 1.57B
Revenue (ttm) 1.13B
Net Income (ttm) 223.60M
Shares Out 57.21M
EPS (ttm) 3.89
PE Ratio 7.03
Forward PE n/a
Dividend $0.30 (1.10%)
Ex-Dividend Date Aug 25, 2022
Volume 568,493
Open 26.34
Previous Close 26.39
Day's Range 25.69 - 27.68
52-Week Range 22.30 - 49.00
Beta n/a
Analysts Sell
Price Target 27.03 (-1.21%)
Earnings Date Feb 14, 2023

About EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, ... [Read more]

Sector Healthcare
Founded 1924
Employees 1,900
Stock Exchange NASDAQ
Ticker Symbol EMBC
Full Company Profile

Financial Performance

In 2022, Embecta's revenue was $1.13 billion, a decrease of -3.07% compared to the previous year's $1.17 billion. Earnings were $223.60 million, a decrease of -46.09%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for EMBC stock is "Sell." The 12-month stock price forecast is $27.03, which is a decrease of -1.21% from the latest price.

Price Target
$27.03
(-1.21% downside)
Analyst Consensus: Sell
Stock Forecasts

News

embecta opens new global headquarters in Parsippany, N.J.

PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spinoff fro...

1 week ago - GlobeNewsWire

embecta to Report Fiscal First Quarter 2023 Financial Results

PARSIPPANY, N.J., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss ...

1 week ago - GlobeNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC

NEW YORK , Jan. 19, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are advised to contac...

1 week ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Embecta Corp. - EMBC

New York, New York--(Newsfile Corp. - January 7, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are a...

3 weeks ago - Newsfile Corp

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Embecta Corp. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 6, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Em...

3 weeks ago - Newsfile Corp

EMBECTA ALERT: Bragar Eagel & Squire, P.C. is Investigating Embecta Corp. on Behalf of Embecta Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Embecta Corp. (“Embecta” or the “Company”) (NAS...

3 weeks ago - Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Embecta Corp. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Embecta Corp. (“Embecta” or “the...

3 weeks ago - Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Embecta Corp. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Embecta Corp. (“Embecta” or “the...

1 month ago - Business Wire

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Embecta Corp. (EMBC)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Embecta Corporation (“Embecta” or the “Company”) (NASDAQ: EMBC). The investigation concerns w...

1 month ago - Business Wire

Embecta Corp. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial results for th...

1 month ago - GlobeNewsWire

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (NASDAQ: EMBC) have declared a quarterly cash dividend of $0.15 for each issued and outstanding ...

1 month ago - GlobeNewsWire

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wed...

1 month ago - GlobeNewsWire

Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes

FREMONT, Calif. and PARSIPPANY, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ: EMBC) today announced they have signed a co-promotional agreement u...

3 months ago - GlobeNewsWire

embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results

PARSIPPANY, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss ...

3 months ago - GlobeNewsWire

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

Advocacy and professional groups including Beyond Type 1, Beyond Type 2, Camp Nejeda, Children with Diabetes, DiabetesSisters, diaTribe Foundation, The Diabetes Foundation, The Diabetes Link and ADCES...

3 months ago - GlobeNewsWire

3 Hidden Gem Stock Picks to Beat the September Market Slump

These days the most popular stocks to follow are either meme plays or the most blue-chip S&P 500 companies. Very few investors seem to be interested in hidden gem stock picks.

Other symbols: JBGSMLI
5 months ago - InvestorPlace

embecta to Participate in Upcoming Investor Conferences in September

PARSIPPANY, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences:

5 months ago - GlobeNewsWire

Embecta Corp. Reports Third Quarter Fiscal 2022 Financial Results

PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off fr...

6 months ago - GlobeNewsWire

embecta Announces Inaugural Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies, announced today that its Board of Directors declared...

6 months ago - GlobeNewsWire

embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022

PARSIPPANY, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off fr...

7 months ago - GlobeNewsWire

Spinoffs Roundup: These Companies Could Unlock Value in 2022

Spinoffs are known for being a mixed bag from the investor's viewpoint. Some of them can unlock the true value of businesses by allowing them to focus on their niches rather than being hampered by und...

Other symbols: BBUCCEGESABZIMV
8 months ago - GuruFocus

Why Embecta Shares Are Falling Today

Becton Dickinson and Co's (NYSE: BDX) pure-play diabetes spin-off Embecta Corp (NASDAQ: EMBC) has reported Q2 sales of $274.5 million, down 3.4% on a reported basis, down 1.3% on a constant currency b...

9 months ago - Benzinga

Embecta Corp. Reports Second Quarter and First Six Months of Fiscal Year 2022 Financial Results and Provides Financial Guidance for the Last Six Months of Fiscal Year 2022

PARSIPPANY, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off fro...

9 months ago - GlobeNewsWire

embecta Announces Second Quarter 2022 Earnings Conference Call Information

FRANKLIN LAKES, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) today announced that it will report its financial results for the second quarter of fiscal year 2022 bef...

10 months ago - GlobeNewsWire

Becton Dickinson Spinoff Embecta Is a Stock to Watch

Embecta Corp. ( EMBC , Financial) may be new to the public markets, but it is well-established in the diabetes field and now free from the control of Becton, Dickinson and Co. ( BDX , Financial) to im...

10 months ago - GuruFocus